Manige Konig

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Roux En Y Gastric Bypass

Community Dwelling

Randomized Controlled Trial

Top Venues

Diabetes, obesity & metabolism

Cardiovascular diabetology

This page only lists publications with an associated author ORCID identifier.

Publications

Anita Y M Kwan, Ulagamadesan Venkatesan, Jan Basile, Denis Xavier, Juan M Maldonado, Sohini Raha, Manige Konig
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial. Diabetes care 45 (3) (2022)
W Timothy Garvey, Guillermo E Umpierrez, Julia P Dunn, Anita Y M Kwan, Oralee J Varnado, Manige Konig, Joshua A Levine
Examining the evidence for weight management in individuals with type 2 diabetes. Diabetes, obesity & metabolism 24 (8) (2022)
Lai San Tham, Kevin M Pantalone, Kathleen M Dungan, Kashif M Munir, Cheng Cai Tang, Manige Konig, Anita Y M Kwan
A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide. Diabetes, obesity & metabolism (2021)
Manige Konig, Matthew C Riddle, Helen M Colhoun, Kelley R Branch, Charles M Atisso, Mark C Lakshmanan, Reema Mody, Sohini Raha, Hertzel C Gerstein
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND. Cardiovascular diabetology 20 (1) (2021)
Juan Pablo Frias, Enzo Bonora, Luis Nevárez Ruiz, Stanley H Hsia, Heike Jung, Sohini Raha, David A Cox, M Angelyn Bethel, Manige Konig
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial. Diabetes, obesity & metabolism 23 (10) (2021)